Comparison of resmetirom quantative analysis in API and formulation models based on PXRD, FTIR and Raman scanning imaging combined with univariate and multivariate analyses
Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperatur...
Saved in:
Published in | Talanta (Oxford) Vol. 287; p. 127568 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
15.05.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H2O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R2 = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R2 = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated).
[Display omitted]
•First report of resmetirom polymorph qualification in formulation models.•The Raman spectra of resmetirom of dihydrate and the anhydrous forms was reported for the first time.•Univariate and multivariate analytical models were established and compared.•PLSR models were constructed combined with pre-processing methods. |
---|---|
AbstractList | Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H2O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R2 = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R2 = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated).Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H2O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R2 = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R2 = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated). Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated). Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H2O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R2 = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R2 = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated). [Display omitted] •First report of resmetirom polymorph qualification in formulation models.•The Raman spectra of resmetirom of dihydrate and the anhydrous forms was reported for the first time.•Univariate and multivariate analytical models were established and compared.•PLSR models were constructed combined with pre-processing methods. Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H₂O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H₂O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R² = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R² = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated). |
ArticleNumber | 127568 |
Author | Zhu, Xueyan Yang, Chen Sun, Wenxia Liu, Xiangkui Luo, Ying |
Author_xml | – sequence: 1 givenname: Chen surname: Yang fullname: Yang, Chen organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China – sequence: 2 givenname: Ying surname: Luo fullname: Luo, Ying organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China – sequence: 3 givenname: Wenxia surname: Sun fullname: Sun, Wenxia organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China – sequence: 4 givenname: Xiangkui surname: Liu fullname: Liu, Xiangkui email: liuxiangkui@sinopharm.com organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China – sequence: 5 givenname: Xueyan surname: Zhu fullname: Zhu, Xueyan organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39923672$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc9u1DAQxi1URLeFRwD5yIEs_pM4yQlVW1pWqkS1KhI3y7EnxavY3trJor4TD1mnuyBuPY1m5vd9tuY7Qyc-eEDoPSVLSqj4vF2OalB-VEtGWLWkrK5E8wotaFPzglc1P0ELQnhbtLQkp-gspS0hhHHC36BT3raMi5ot0J9VcDsVbQoehx5HSA5GG4PDD9PsPto9YOXV8Jhswtbji9t17g3uQ3TTkPdZ6IKBIeFOJTA497c_N5ef8NXdevOMbpRTHietvLf-Hlun7ueqg-usz4rfdvyFJ2_3-R9qhGdN9h7_G8zvQ3qLXvdqSPDuWM_Rj6uvd6tvxc336_Xq4qbQvBRjwfpGUGB1D6CMIUQbRjUxtSj7uuKcNW3fCtV0ddlp3RgBdWOqind9SWhPCPBz9PHgu4vhYYI0SmeThiHfG8KUJGclI1UriHgZpaIiTQZn9MMRnToHRu5ivkR8lH_DyEB1AHQMKUXo_yGUyDl0uZXH0OUcujyEnnVfDrocAuwtRJm0Ba_B2Ah6lCbYFxyeABF8ugA |
Cites_doi | 10.1016/j.xphs.2019.06.024 10.1016/S0165-9936(02)01208-6 10.1016/j.jpba.2009.09.021 10.1364/AO.463293 10.1111/liv.15930 10.1016/j.saa.2024.124858 10.1016/S0169-7439(01)00155-1 10.1016/S0169-409X(01)00099-0 10.2174/2210309005666150128003150 10.1002/jps.24160 10.1016/j.powtec.2018.06.025 10.1016/j.jpba.2008.11.033 10.1038/s41591-023-02603-1 10.1016/j.saa.2023.122458 10.3390/ijms23169013 10.1016/j.ijpharm.2008.10.010 10.1016/S0003-2670(96)00425-4 10.1016/j.isci.2022.105871 10.5740/jaoacint.19-0201 10.1016/j.saa.2020.118900 10.1016/j.jpba.2006.08.030 10.1016/j.jpba.2010.12.020 10.1016/j.talanta.2019.03.027 10.1023/A:1018956304595 10.1016/j.ijpharm.2010.07.043 10.1016/j.jpba.2012.01.013 10.1016/j.foodchem.2023.137300 10.1016/S0731-7085(02)00053-5 10.1016/j.saa.2022.120996 10.1016/j.jpba.2015.06.011 10.1016/j.jpba.2015.01.005 10.1080/03639045.2023.2290021 10.1016/S0378-5173(98)00335-4 10.1177/00037028231152497 10.1016/j.jpba.2013.12.001 10.1016/j.jpba.2017.02.053 10.1007/s00223-007-9007-3 10.1016/j.jpba.2008.09.054 10.1016/j.ssnmr.2011.03.007 10.1016/j.molliq.2022.120857 10.1002/biot.200900284 10.1016/j.jpba.2018.05.026 10.1016/j.xphs.2022.09.009 10.1016/j.cclet.2016.03.042 10.1186/s13065-021-00752-3 |
ContentType | Journal Article |
Copyright | 2025 Copyright © 2025. Published by Elsevier B.V. |
Copyright_xml | – notice: 2025 – notice: Copyright © 2025. Published by Elsevier B.V. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1016/j.talanta.2025.127568 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1873-3573 |
ExternalDocumentID | 39923672 10_1016_j_talanta_2025_127568 S0039914025000542 |
Genre | Journal Article Comparative Study |
GroupedDBID | --K --M -DZ -~X .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 5VS 7-5 71M 8P~ 9JN AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATTM AAXKI AAXUO AAYWO ABJNI ABMAC ACDAQ ACGFS ACNCT ACRLP ACVFH ADBBV ADCNI ADECG ADEZE AEBSH AEIPS AEKER AENEX AEUPX AFJKZ AFPUW AFTJW AFXIZ AFZHZ AGCQF AGHFR AGRNS AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJSZI AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM M36 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RNS ROL RPZ SCC SCH SDF SDG SDP SES SEW SPC SPCBC SSH SSK SSZ T5K TN5 TWZ WH7 XPP YK3 YNT ZMT ~02 ~G- 29Q 3O- 53G AAQXK AAYJJ AAYXX ABDPE ABEFU ABFNM ABWVN ABXDB ACNNM ACRPL ADIYS ADMUD ADNMO AGQPQ AJQLL ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB HMU HVGLF HZ~ R2- RIG SCB WUQ XOL AACTN CGR CUY CVF ECM EIF K-O NPM 7X8 7S9 EFKBS L.6 |
ID | FETCH-LOGICAL-c346t-2f861e27feeadd00cd21c0d764f7533289f96a8b74bcc8d6e78d553bf401f00e3 |
IEDL.DBID | .~1 |
ISSN | 0039-9140 1873-3573 |
IngestDate | Fri Aug 22 20:24:55 EDT 2025 Fri Jul 11 04:21:09 EDT 2025 Fri May 09 01:30:34 EDT 2025 Thu Jul 03 08:26:57 EDT 2025 Sat Jul 05 17:11:13 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Resmetirom Raman Quantitative FTIR Polymorphism PXRD |
Language | English |
License | Copyright © 2025. Published by Elsevier B.V. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c346t-2f861e27feeadd00cd21c0d764f7533289f96a8b74bcc8d6e78d553bf401f00e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 39923672 |
PQID | 3165080636 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_3242059606 proquest_miscellaneous_3165080636 pubmed_primary_39923672 crossref_primary_10_1016_j_talanta_2025_127568 elsevier_sciencedirect_doi_10_1016_j_talanta_2025_127568 |
PublicationCentury | 2000 |
PublicationDate | 2025-05-15 |
PublicationDateYYYYMMDD | 2025-05-15 |
PublicationDate_xml | – month: 05 year: 2025 text: 2025-05-15 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Talanta (Oxford) |
PublicationTitleAlternate | Talanta |
PublicationYear | 2025 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Shi, Wang, Wang, Song, Liu, Wu, Gong (bib10) 2021; 14 Schulz, Pretzsch, Khalaf, Deiwick, Scheidt, Salis-Soglio, Bader, Huster (bib28) 2007 Apr; 80 Saha, Singh, Paul, Sarkar, Khan, Banerjee (bib20) 2020 Jan 1; 103 Vankeirsbilck, Vercauteren, Baeyens, Van der Weken, Verpoort, Vergote, Remon (bib51) 2002; 21 Liu, Liu, Wang, Song, Li, Wu, Gong (bib11) 2023 May 15; 293 Breitenbach, Schrof, Neumann (bib52) 1999 Jul; 16 Chieng, Rehder, Saville, Rades, Aaltonen (bib22) 2009 Jan 15; 49 Chen, Stowell, Morris, Byrn (bib38) 2010 Mar 11; 51 Bansal, Singh, Kaur (bib17) 2021 Apr 24; 15 Takehira, Momose, Yamamura (bib39) 2010 Oct 15; 398 Bhavana, Chavan, Mannava, Nangia, Shastri (bib19) 2019 Jul 1; 199 Wu, Du, Ma, Zhang, Yang, Liu, Zhang (bib26) 2024 Feb 1; 433 Wang, Shi, Hou, Li, Wang, Yang, Cao (bib29) 2023 Feb 15; 287 Hurst, Schroeder, Styron (bib42) 1997; 337 (bib1) 2006 Meng, Ciyong, Li, Zhao, Zhang, Du (bib21) 2022 Jul 20; 61 Német, Kis, Pokol, Demeter (bib40) 2009 Feb 20; 49 Bakkar, Nawaz, Majeed, Naseem, Ditta, Rashid, Ali, Bajwa, Bashir, Ahmad, Hyat, Bukhari, Bonnier (bib41) 2021 Jan 15; 245 Takehira, Momose, Yamamura (bib43) 2010 Oct 15; 398 Skrdla, Zhang (bib34) 2014 Mar; 90 Inoue, Osada, Hisada, Koide, Fukami, Roy, Carriere (bib24) 2023 Jan; 112 Shafaq, Majeed, Nawaz (bib45) 2022; 272 Braga, Casali, Grepioni (bib2) 2022 Aug 12; 23 Tian, Luo, Lou (bib8) 2023; 369 Tiwari, Chawla, Bansal (bib37) 2007 Feb 19; 43 Wold, Sjöström, Eriksson (bib46) 2001; 58 Campbell Roberts, Williams, Grimsey, Booth (bib36) 2002 Jun 15; 28 Croker, Hennigan, Maher, Hu, Ryder, Hodnett (bib49) 2012 Apr 7; 63 Zhao, Zheng, Li (bib13) 2016; 27 Sheokand, Modi, Bansal (bib33) 2014 Nov; 103 Tiwari, Chawla, Bansal (bib50) 2007 Feb 19; 43 Bellur Atici, Karlığa (bib16) 2015 Oct 10; 114 Qiu, Li, Sheng, Zhu (bib44) 2015 Mar 25; 107 Guirguis, Dougherty, Thornby, Grace, Mack (bib7) 2024 Jun; 17 Németh, Rákosa (bib47) 2023 Apr; 77 Ji, Zhu, Deng, Jiang, Chen (bib15) 2024 Dec 15; 323 Harrison, Taub, Neff, Lucas, Labriola, Moussa, Alkhouri, Bashir (bib6) 2023 Nov; 29 Dharani, Barakh Ali, Afrooz, Khan, Rahman (bib14) 2019 Nov; 108 Ghafoor, Kanwal, Nawaz, Irfan Majeed, Rashid, Ishtiaq, Tariq, Kainat, Ali, Anwar, Shoukat, Amir, Imran (bib25) 2024 Jan; 50 Guo, Luo, Zhou (bib35) 2017; 140 Buckton, D (bib12) 1999; 179 Achata, Esquerre, Gowen (bib18) 2018; 336 Kang, Shao, Wang, Hu, Yu (bib23) 2018 Sep 5; 158 Jiang, Huang, Dai, Hunger (bib27) 2011 May-Jun; 39 Xiong, Huaxin, Wu (bib31) 2015; 50 Petta, Targher, Romeo, Pajvani, Zheng, Aghemo, Valenti (bib5) 2024 Jul; 44 Shi, Li, Wang, Wang, Yang (bib30) 2022 Dec 24; 26 Mahmoudi, Fattahi-Asl, Hosseinzadeh (bib9) 2014; 4 Chieng, Rades, Aaltonen (bib32) 2011 Jun 25; 55 Zhao, Zhang, Liu (bib48) 2010 May; 5 Kamada, Yoshimura, Murata, Murata, Nagai, Ushio, Terada (bib4) 2009 Feb 23; 368 Stephenson, Forbes, Reutzel-Edens (bib3) 2001 May 16; 48 Vankeirsbilck (10.1016/j.talanta.2025.127568_bib51) 2002; 21 Wang (10.1016/j.talanta.2025.127568_bib29) 2023; 287 Tiwari (10.1016/j.talanta.2025.127568_bib50) 2007; 43 Schulz (10.1016/j.talanta.2025.127568_bib28) 2007; 80 Croker (10.1016/j.talanta.2025.127568_bib49) 2012; 63 Shafaq (10.1016/j.talanta.2025.127568_bib45) 2022; 272 Sheokand (10.1016/j.talanta.2025.127568_bib33) 2014; 103 Zhao (10.1016/j.talanta.2025.127568_bib13) 2016; 27 Bellur Atici (10.1016/j.talanta.2025.127568_bib16) 2015; 114 Mahmoudi (10.1016/j.talanta.2025.127568_bib9) 2014; 4 Zhao (10.1016/j.talanta.2025.127568_bib48) 2010; 5 Buckton (10.1016/j.talanta.2025.127568_bib12) 1999; 179 Bansal (10.1016/j.talanta.2025.127568_bib17) 2021; 15 Takehira (10.1016/j.talanta.2025.127568_bib43) 2010; 398 Bhavana (10.1016/j.talanta.2025.127568_bib19) 2019; 199 Harrison (10.1016/j.talanta.2025.127568_bib6) 2023; 29 Qiu (10.1016/j.talanta.2025.127568_bib44) 2015; 107 Petta (10.1016/j.talanta.2025.127568_bib5) 2024; 44 Wold (10.1016/j.talanta.2025.127568_bib46) 2001; 58 Chieng (10.1016/j.talanta.2025.127568_bib32) 2011; 55 Chieng (10.1016/j.talanta.2025.127568_bib22) 2009; 49 Ghafoor (10.1016/j.talanta.2025.127568_bib25) 2024; 50 Kamada (10.1016/j.talanta.2025.127568_bib4) 2009; 368 Kang (10.1016/j.talanta.2025.127568_bib23) 2018; 158 Jiang (10.1016/j.talanta.2025.127568_bib27) 2011; 39 Stephenson (10.1016/j.talanta.2025.127568_bib3) 2001; 48 Shi (10.1016/j.talanta.2025.127568_bib10) 2021; 14 Hurst (10.1016/j.talanta.2025.127568_bib42) 1997; 337 Tian (10.1016/j.talanta.2025.127568_bib8) 2023; 369 Wu (10.1016/j.talanta.2025.127568_bib26) 2024; 433 Saha (10.1016/j.talanta.2025.127568_bib20) 2020; 103 Achata (10.1016/j.talanta.2025.127568_bib18) 2018; 336 Chen (10.1016/j.talanta.2025.127568_bib38) 2010; 51 Német (10.1016/j.talanta.2025.127568_bib40) 2009; 49 Liu (10.1016/j.talanta.2025.127568_bib11) 2023; 293 Guo (10.1016/j.talanta.2025.127568_bib35) 2017; 140 Skrdla (10.1016/j.talanta.2025.127568_bib34) 2014; 90 Németh (10.1016/j.talanta.2025.127568_bib47) 2023; 77 Inoue (10.1016/j.talanta.2025.127568_bib24) 2023; 112 Campbell Roberts (10.1016/j.talanta.2025.127568_bib36) 2002; 28 Takehira (10.1016/j.talanta.2025.127568_bib39) 2010; 398 Guirguis (10.1016/j.talanta.2025.127568_bib7) 2024; 17 Bakkar (10.1016/j.talanta.2025.127568_bib41) 2021; 245 Tiwari (10.1016/j.talanta.2025.127568_bib37) 2007; 43 Braga (10.1016/j.talanta.2025.127568_bib2) 2022; 23 Xiong (10.1016/j.talanta.2025.127568_bib31) 2015; 50 Breitenbach (10.1016/j.talanta.2025.127568_bib52) 1999; 16 Ji (10.1016/j.talanta.2025.127568_bib15) 2024; 323 Dharani (10.1016/j.talanta.2025.127568_bib14) 2019; 108 Shi (10.1016/j.talanta.2025.127568_bib30) 2022; 26 Meng (10.1016/j.talanta.2025.127568_bib21) 2022; 61 (10.1016/j.talanta.2025.127568_bib1) 2006 |
References_xml | – volume: 28 start-page: 1149 year: 2002 Jun 15 end-page: 1159 ident: bib36 article-title: Quantitative analysis of mannitol polymorphs. X-ray powder diffractometry--exploring preferred orientation effects publication-title: J. Pharm. Biomed. Anal. – volume: 17 year: 2024 Jun ident: bib7 article-title: Resmetirom: the first food and drug administration-approved medication for nonalcoholic steatohepatitis (NASH) publication-title: Ann. Pharmacother. – volume: 21 start-page: 869 year: 2002 end-page: 877 ident: bib51 article-title: Applications of Raman spectroscopy in pharmaceutical analysis publication-title: TrAC Trends Anal. Chem. – volume: 5 start-page: 493 year: 2010 May end-page: 504 ident: bib48 article-title: Pretreatment of Siam weed stem by several chemical methods for increasing the enzymatic digestibility publication-title: Biotechnol. J. – volume: 80 start-page: 275 year: 2007 Apr end-page: 285 ident: bib28 article-title: Quantitative monitoring of extracellular matrix production in bone implants by 13C and 31P solid-state nuclear magnetic resonance spectroscopy publication-title: Calcif. Tissue Int. – volume: 26 year: 2022 Dec 24 ident: bib30 article-title: Quantitative detection of THz-ATR spectra of aqueous samples under strong-field terahertz wave publication-title: iScience – volume: 44 start-page: 1526 year: 2024 Jul end-page: 1536 ident: bib5 article-title: The first MASH drug therapy on the horizon: current perspectives of resmetirom publication-title: Liver Int. – volume: 337 year: 1997 ident: bib42 article-title: Accurate quantification of quartz and other phases by powder X-ray diffractometry publication-title: Anal. Chim. Acta – volume: 50 start-page: 1 year: 2024 Jan end-page: 10 ident: bib25 article-title: Quantitative analysis of cephalexin in solid dosage form by Raman spectroscopy and chemometric tools publication-title: Drug Dev. Ind. Pharm. – volume: 114 start-page: 330 year: 2015 Oct 10 end-page: 340 ident: bib16 article-title: Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy publication-title: J. Pharm. Biomed. Anal. – volume: 103 start-page: 3364 year: 2014 Nov end-page: 3376 ident: bib33 article-title: Dynamic vapor sorption as a tool for characterization and quantification of amorphous content in predominantly crystalline materials publication-title: J Pharm Sci – volume: 336 start-page: 555 year: 2018 end-page: 566 ident: bib18 article-title: Feasibility of near infrared and Raman hyperspectral imaging combined with multivariate analysis to assess binary mixtures of food powders publication-title: Powder Technol. – volume: 14 year: 2021 ident: bib10 article-title: Quantitative analysis of binary mixtures of entecavir using solid-state analytical techniques with chemometric methods publication-title: Arab. J. Chem. – volume: 50 start-page: 532 year: 2015 end-page: 535 ident: bib31 article-title: Moisture sorption properties research of chemical reference substances based on dynamic vapor sorption analysis technology publication-title: Chin Pharm J – volume: 27 start-page: 1666 year: 2016 end-page: 1672 ident: bib13 article-title: Quantification of flupirtine maleate polymorphs using X-ray powder diffraction publication-title: Chin. Chem. Lett. – volume: 199 start-page: 679 year: 2019 Jul 1 end-page: 688 ident: bib19 article-title: Quantification of niclosamide polymorphic forms - a comparative study by Raman, NIR and MIR using chemometric techniques publication-title: Talanta – volume: 398 start-page: 33 year: 2010 Oct 15 end-page: 38 ident: bib43 article-title: Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern publication-title: Int J Pharm – volume: 108 start-page: 3575 year: 2019 Nov end-page: 3581 ident: bib14 article-title: Univariate and multivariate models for determination of prasugrel base in the formulation of prasugrel hydrochloride using XRPD method publication-title: J Pharm Sci – volume: 103 start-page: 23 year: 2020 Jan 1 end-page: 39 ident: bib20 article-title: Anthocyanin profiling using UV-vis spectroscopy and liquid chromatography mass spectrometry publication-title: J. AOAC Int. – volume: 179 start-page: 141 year: 1999 end-page: 158 ident: bib12 publication-title: Int. J. Pharm. – volume: 58 start-page: 109 year: 2001 end-page: 130 ident: bib46 article-title: PLS-regression: a basic tool of chemometrics publication-title: Chemometr. Intell. Lab. Syst. – volume: 63 start-page: 80 year: 2012 Apr 7 end-page: 86 ident: bib49 article-title: A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetam publication-title: J. Pharm. Biomed. Anal. – volume: 29 start-page: 2919 year: 2023 Nov end-page: 2928 ident: bib6 article-title: Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial publication-title: Nat Med – volume: 140 start-page: 130 year: 2017 end-page: 136 ident: bib35 article-title: Quantitative analysis of binary polymorphs mixtures of fusidic acid by diffuse reflectance FTIR spectroscopy, diffuse reflectance FT NIR spectroscopy, Raman spectroscopy and multivariate calibration publication-title: J. Pharm. Biomed. Anal. – volume: 48 start-page: 67 year: 2001 May 16 end-page: 90 ident: bib3 article-title: Characterization of the solid state: quantitative issues publication-title: Adv. Drug Deliv. Rev. – volume: 77 start-page: 350 year: 2023 Apr end-page: 359 ident: bib47 article-title: Congruence concept for comparison of spectra publication-title: Appl. Spectrosc. – volume: 369 year: 2023 ident: bib8 article-title: Screening, packing systematics, Hansen solubility parameters and desolvation of resmetirom (MGL-3196) solvates publication-title: J. Mol. Liq. – volume: 368 start-page: 103 year: 2009 Feb 23 end-page: 108 ident: bib4 article-title: Characterization and monit-oring of pseudo-polymorphs in manufacturing process by NIR publication-title: Int J Pharm – volume: 43 start-page: 865 year: 2007 Feb 19 end-page: 872 ident: bib37 article-title: Quantification of olanzapine polymorphs using powder X-ray diffraction technique publication-title: J. Pharm. Biomed. Anal. – volume: 39 start-page: 116 year: 2011 May-Jun end-page: 141 ident: bib27 article-title: Solid-state nuclear magnetic resonance investigations of the nature, property, and activity of acid sites on solid catalysts publication-title: Solid State Nucl. Magn. Reson. – volume: 287 year: 2023 Feb 15 ident: bib29 article-title: Quantitative analysis of aqueous biomolecular mixtures by THz spectroscopy based on high-power LiNbO3 radiation source publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. – volume: 112 start-page: 225 year: 2023 Jan end-page: 229 ident: bib24 article-title: Quantitative monitoring of cocrystal polymorphisms in model tablets using transmission low-frequency Raman spectroscopy publication-title: J Pharm Sci – volume: 433 year: 2024 Feb 1 ident: bib26 article-title: Qualitative and quantitative studies of phthalates in extra virgin olive oil (EVOO) by surface-enhanced Raman spectroscopy (SERS) combined with long short term memory (LSTM) neural network publication-title: Food Chem. – volume: 272 year: 2022 ident: bib45 article-title: Quantitative analysis of solid dosage forms of Losartan potassium by Raman spectroscopy publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. – volume: 107 start-page: 298 year: 2015 Mar 25 end-page: 303 ident: bib44 article-title: Quantification of febuxostat polymorphs using powder X-ray diffraction technique publication-title: J. Pharm. Biomed. Anal. – volume: 61 start-page: 6186 year: 2022 Jul 20 end-page: 6192 ident: bib21 article-title: Application of ultraviolet-visible spectroscopy coupled with support vector regression for the quantitative detection of thiamethoxam in tea publication-title: Appl. Opt. – volume: 55 start-page: 618 year: 2011 Jun 25 end-page: 644 ident: bib32 article-title: An overview of recent studies on the analysis of pharmaceutical polymorphs publication-title: J. Pharm. Biomed. Anal. – volume: 90 start-page: 186 year: 2014 Mar end-page: 191 ident: bib34 article-title: Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC publication-title: J. Pharm. Biomed. Anal. – volume: 23 start-page: 9013 year: 2022 Aug 12 ident: bib2 article-title: The relevance of crystal forms in the pharmaceutical field: sword of damocles or innovation tools? publication-title: Int. J. Mol. Sci. – volume: 49 start-page: 18 year: 2009 Jan 15 end-page: 25 ident: bib22 article-title: Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction publication-title: J. Pharm. Biomed. Anal. – volume: 293 year: 2023 May 15 ident: bib11 article-title: Quantitative analysis of low content polymorphic impurities in canagliflozin tablets by PXRD, NIR, ATR-FITR and Raman solid-state analysis techniques combined with stoichiometry publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. – volume: 16 start-page: 1109 year: 1999 Jul end-page: 1113 ident: bib52 article-title: Confocal Raman-spectroscopy: analytical approach to solid dispersions and mapping of drugs publication-title: Pharm. Res. (N. Y.) – volume: 49 start-page: 338 year: 2009 Feb 20 end-page: 346 ident: bib40 article-title: Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study publication-title: J. Pharm. Biomed. Anal. – volume: 398 start-page: 33 year: 2010 Oct 15 end-page: 38 ident: bib39 article-title: Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern publication-title: Int J Pharm – volume: 43 start-page: 865 year: 2007 Feb 19 end-page: 872 ident: bib50 article-title: Quantification of olanzapine polymorphs using powder X-ray diffraction technique publication-title: J. Pharm. Biomed. Anal. – volume: 158 start-page: 28 year: 2018 Sep 5 end-page: 37 ident: bib23 article-title: Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy publication-title: J. Pharm. Biomed. Anal. – volume: 323 year: 2024 Dec 15 ident: bib15 article-title: Quantitative determination of zearalenone in wheat by the CSA-NIR technique combined with chemometrics algorithms publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. – volume: 15 start-page: 27 year: 2021 Apr 24 ident: bib17 article-title: Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes publication-title: BMC Chem – year: 2006 ident: bib1 publication-title: The Pharmaceutical Industry – volume: 51 start-page: 866 year: 2010 Mar 11 end-page: 874 ident: bib38 article-title: Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction publication-title: J. Pharm. Biomed. Anal. – volume: 245 year: 2021 Jan 15 ident: bib41 article-title: Raman spectroscopy for the qualitative and quantitative analysis of solid dosage forms of Sitagliptin publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. – volume: 4 start-page: 180 year: 2014 end-page: 184 ident: bib9 article-title: Effects of 900mhz mobile phone radiation on human thyroid hormone levels publication-title: Recent Pat. Biomarkers – volume: 108 start-page: 3575 issue: 11 year: 2019 ident: 10.1016/j.talanta.2025.127568_bib14 article-title: Univariate and multivariate models for determination of prasugrel base in the formulation of prasugrel hydrochloride using XRPD method publication-title: J Pharm Sci doi: 10.1016/j.xphs.2019.06.024 – volume: 21 start-page: 869 year: 2002 ident: 10.1016/j.talanta.2025.127568_bib51 article-title: Applications of Raman spectroscopy in pharmaceutical analysis publication-title: TrAC Trends Anal. Chem. doi: 10.1016/S0165-9936(02)01208-6 – volume: 51 start-page: 866 issue: 4 year: 2010 ident: 10.1016/j.talanta.2025.127568_bib38 article-title: Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2009.09.021 – volume: 61 start-page: 6186 issue: 21 year: 2022 ident: 10.1016/j.talanta.2025.127568_bib21 article-title: Application of ultraviolet-visible spectroscopy coupled with support vector regression for the quantitative detection of thiamethoxam in tea publication-title: Appl. Opt. doi: 10.1364/AO.463293 – volume: 44 start-page: 1526 issue: 7 year: 2024 ident: 10.1016/j.talanta.2025.127568_bib5 article-title: The first MASH drug therapy on the horizon: current perspectives of resmetirom publication-title: Liver Int. doi: 10.1111/liv.15930 – volume: 323 year: 2024 ident: 10.1016/j.talanta.2025.127568_bib15 article-title: Quantitative determination of zearalenone in wheat by the CSA-NIR technique combined with chemometrics algorithms publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. doi: 10.1016/j.saa.2024.124858 – volume: 58 start-page: 109 issue: 2 year: 2001 ident: 10.1016/j.talanta.2025.127568_bib46 article-title: PLS-regression: a basic tool of chemometrics publication-title: Chemometr. Intell. Lab. Syst. doi: 10.1016/S0169-7439(01)00155-1 – volume: 48 start-page: 67 issue: 1 year: 2001 ident: 10.1016/j.talanta.2025.127568_bib3 article-title: Characterization of the solid state: quantitative issues publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(01)00099-0 – volume: 4 start-page: 180 issue: 3 year: 2014 ident: 10.1016/j.talanta.2025.127568_bib9 article-title: Effects of 900mhz mobile phone radiation on human thyroid hormone levels publication-title: Recent Pat. Biomarkers doi: 10.2174/2210309005666150128003150 – volume: 103 start-page: 3364 issue: 11 year: 2014 ident: 10.1016/j.talanta.2025.127568_bib33 article-title: Dynamic vapor sorption as a tool for characterization and quantification of amorphous content in predominantly crystalline materials publication-title: J Pharm Sci doi: 10.1002/jps.24160 – volume: 14 year: 2021 ident: 10.1016/j.talanta.2025.127568_bib10 article-title: Quantitative analysis of binary mixtures of entecavir using solid-state analytical techniques with chemometric methods publication-title: Arab. J. Chem. – volume: 336 start-page: 555 year: 2018 ident: 10.1016/j.talanta.2025.127568_bib18 article-title: Feasibility of near infrared and Raman hyperspectral imaging combined with multivariate analysis to assess binary mixtures of food powders publication-title: Powder Technol. doi: 10.1016/j.powtec.2018.06.025 – volume: 49 start-page: 338 issue: 2 year: 2009 ident: 10.1016/j.talanta.2025.127568_bib40 article-title: Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2008.11.033 – volume: 29 start-page: 2919 issue: 11 year: 2023 ident: 10.1016/j.talanta.2025.127568_bib6 article-title: Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial publication-title: Nat Med doi: 10.1038/s41591-023-02603-1 – volume: 293 year: 2023 ident: 10.1016/j.talanta.2025.127568_bib11 article-title: Quantitative analysis of low content polymorphic impurities in canagliflozin tablets by PXRD, NIR, ATR-FITR and Raman solid-state analysis techniques combined with stoichiometry publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. doi: 10.1016/j.saa.2023.122458 – volume: 23 start-page: 9013 issue: 16 year: 2022 ident: 10.1016/j.talanta.2025.127568_bib2 article-title: The relevance of crystal forms in the pharmaceutical field: sword of damocles or innovation tools? publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms23169013 – volume: 368 start-page: 103 issue: 1–2 year: 2009 ident: 10.1016/j.talanta.2025.127568_bib4 article-title: Characterization and monit-oring of pseudo-polymorphs in manufacturing process by NIR publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2008.10.010 – volume: 337 year: 1997 ident: 10.1016/j.talanta.2025.127568_bib42 article-title: Accurate quantification of quartz and other phases by powder X-ray diffractometry publication-title: Anal. Chim. Acta doi: 10.1016/S0003-2670(96)00425-4 – year: 2006 ident: 10.1016/j.talanta.2025.127568_bib1 – volume: 26 issue: 1 year: 2022 ident: 10.1016/j.talanta.2025.127568_bib30 article-title: Quantitative detection of THz-ATR spectra of aqueous samples under strong-field terahertz wave publication-title: iScience doi: 10.1016/j.isci.2022.105871 – volume: 103 start-page: 23 issue: 1 year: 2020 ident: 10.1016/j.talanta.2025.127568_bib20 article-title: Anthocyanin profiling using UV-vis spectroscopy and liquid chromatography mass spectrometry publication-title: J. AOAC Int. doi: 10.5740/jaoacint.19-0201 – volume: 245 year: 2021 ident: 10.1016/j.talanta.2025.127568_bib41 article-title: Raman spectroscopy for the qualitative and quantitative analysis of solid dosage forms of Sitagliptin publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. doi: 10.1016/j.saa.2020.118900 – volume: 43 start-page: 865 issue: 3 year: 2007 ident: 10.1016/j.talanta.2025.127568_bib50 article-title: Quantification of olanzapine polymorphs using powder X-ray diffraction technique publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2006.08.030 – volume: 55 start-page: 618 issue: 4 year: 2011 ident: 10.1016/j.talanta.2025.127568_bib32 article-title: An overview of recent studies on the analysis of pharmaceutical polymorphs publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2010.12.020 – volume: 199 start-page: 679 year: 2019 ident: 10.1016/j.talanta.2025.127568_bib19 article-title: Quantification of niclosamide polymorphic forms - a comparative study by Raman, NIR and MIR using chemometric techniques publication-title: Talanta doi: 10.1016/j.talanta.2019.03.027 – volume: 16 start-page: 1109 issue: 7 year: 1999 ident: 10.1016/j.talanta.2025.127568_bib52 article-title: Confocal Raman-spectroscopy: analytical approach to solid dispersions and mapping of drugs publication-title: Pharm. Res. (N. Y.) doi: 10.1023/A:1018956304595 – volume: 398 start-page: 33 issue: 1–2 year: 2010 ident: 10.1016/j.talanta.2025.127568_bib43 article-title: Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2010.07.043 – volume: 63 start-page: 80 year: 2012 ident: 10.1016/j.talanta.2025.127568_bib49 article-title: A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetam publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2012.01.013 – volume: 433 year: 2024 ident: 10.1016/j.talanta.2025.127568_bib26 article-title: Qualitative and quantitative studies of phthalates in extra virgin olive oil (EVOO) by surface-enhanced Raman spectroscopy (SERS) combined with long short term memory (LSTM) neural network publication-title: Food Chem. doi: 10.1016/j.foodchem.2023.137300 – volume: 50 start-page: 532 issue: 6 year: 2015 ident: 10.1016/j.talanta.2025.127568_bib31 article-title: Moisture sorption properties research of chemical reference substances based on dynamic vapor sorption analysis technology publication-title: Chin Pharm J – volume: 28 start-page: 1149 issue: 6 year: 2002 ident: 10.1016/j.talanta.2025.127568_bib36 article-title: Quantitative analysis of mannitol polymorphs. X-ray powder diffractometry--exploring preferred orientation effects publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/S0731-7085(02)00053-5 – volume: 272 year: 2022 ident: 10.1016/j.talanta.2025.127568_bib45 article-title: Quantitative analysis of solid dosage forms of Losartan potassium by Raman spectroscopy publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. doi: 10.1016/j.saa.2022.120996 – volume: 43 start-page: 865 issue: 3 year: 2007 ident: 10.1016/j.talanta.2025.127568_bib37 article-title: Quantification of olanzapine polymorphs using powder X-ray diffraction technique publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2006.08.030 – volume: 17 year: 2024 ident: 10.1016/j.talanta.2025.127568_bib7 article-title: Resmetirom: the first food and drug administration-approved medication for nonalcoholic steatohepatitis (NASH) publication-title: Ann. Pharmacother. – volume: 114 start-page: 330 year: 2015 ident: 10.1016/j.talanta.2025.127568_bib16 article-title: Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2015.06.011 – volume: 107 start-page: 298 year: 2015 ident: 10.1016/j.talanta.2025.127568_bib44 article-title: Quantification of febuxostat polymorphs using powder X-ray diffraction technique publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2015.01.005 – volume: 50 start-page: 1 issue: 1 year: 2024 ident: 10.1016/j.talanta.2025.127568_bib25 article-title: Quantitative analysis of cephalexin in solid dosage form by Raman spectroscopy and chemometric tools publication-title: Drug Dev. Ind. Pharm. doi: 10.1080/03639045.2023.2290021 – volume: 179 start-page: 141 year: 1999 ident: 10.1016/j.talanta.2025.127568_bib12 publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(98)00335-4 – volume: 77 start-page: 350 issue: 4 year: 2023 ident: 10.1016/j.talanta.2025.127568_bib47 article-title: Congruence concept for comparison of spectra publication-title: Appl. Spectrosc. doi: 10.1177/00037028231152497 – volume: 90 start-page: 186 year: 2014 ident: 10.1016/j.talanta.2025.127568_bib34 publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2013.12.001 – volume: 140 start-page: 130 year: 2017 ident: 10.1016/j.talanta.2025.127568_bib35 article-title: Quantitative analysis of binary polymorphs mixtures of fusidic acid by diffuse reflectance FTIR spectroscopy, diffuse reflectance FT NIR spectroscopy, Raman spectroscopy and multivariate calibration publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2017.02.053 – volume: 80 start-page: 275 issue: 4 year: 2007 ident: 10.1016/j.talanta.2025.127568_bib28 article-title: Quantitative monitoring of extracellular matrix production in bone implants by 13C and 31P solid-state nuclear magnetic resonance spectroscopy publication-title: Calcif. Tissue Int. doi: 10.1007/s00223-007-9007-3 – volume: 49 start-page: 18 issue: 1 year: 2009 ident: 10.1016/j.talanta.2025.127568_bib22 article-title: Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2008.09.054 – volume: 39 start-page: 116 issue: 3–4 year: 2011 ident: 10.1016/j.talanta.2025.127568_bib27 article-title: Solid-state nuclear magnetic resonance investigations of the nature, property, and activity of acid sites on solid catalysts publication-title: Solid State Nucl. Magn. Reson. doi: 10.1016/j.ssnmr.2011.03.007 – volume: 369 year: 2023 ident: 10.1016/j.talanta.2025.127568_bib8 article-title: Screening, packing systematics, Hansen solubility parameters and desolvation of resmetirom (MGL-3196) solvates publication-title: J. Mol. Liq. doi: 10.1016/j.molliq.2022.120857 – volume: 5 start-page: 493 issue: 5 year: 2010 ident: 10.1016/j.talanta.2025.127568_bib48 article-title: Pretreatment of Siam weed stem by several chemical methods for increasing the enzymatic digestibility publication-title: Biotechnol. J. doi: 10.1002/biot.200900284 – volume: 158 start-page: 28 year: 2018 ident: 10.1016/j.talanta.2025.127568_bib23 article-title: Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2018.05.026 – volume: 112 start-page: 225 issue: 1 year: 2023 ident: 10.1016/j.talanta.2025.127568_bib24 article-title: Quantitative monitoring of cocrystal polymorphisms in model tablets using transmission low-frequency Raman spectroscopy publication-title: J Pharm Sci doi: 10.1016/j.xphs.2022.09.009 – volume: 27 start-page: 1666 issue: 11 year: 2016 ident: 10.1016/j.talanta.2025.127568_bib13 article-title: Quantification of flupirtine maleate polymorphs using X-ray powder diffraction publication-title: Chin. Chem. Lett. doi: 10.1016/j.cclet.2016.03.042 – volume: 15 start-page: 27 issue: 1 year: 2021 ident: 10.1016/j.talanta.2025.127568_bib17 article-title: Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes publication-title: BMC Chem doi: 10.1186/s13065-021-00752-3 – volume: 287 issue: Pt 2 year: 2023 ident: 10.1016/j.talanta.2025.127568_bib29 article-title: Quantitative analysis of aqueous biomolecular mixtures by THz spectroscopy based on high-power LiNbO3 radiation source publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc. – volume: 398 start-page: 33 issue: 1–2 year: 2010 ident: 10.1016/j.talanta.2025.127568_bib39 article-title: Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2010.07.043 |
SSID | ssj0002303 |
Score | 2.4618516 |
Snippet | Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were... Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H O, were... Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H₂O, were... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 127568 |
SubjectTerms | bioavailability drugs fatty liver FTIR humidity Least-Squares Analysis Multivariate Analysis Polymorphism PXRD Quantitative quantitative analysis Raman Resmetirom Spectroscopy, Fourier Transform Infrared Spectrum Analysis, Raman Tablets temperature X-Ray Diffraction |
Title | Comparison of resmetirom quantative analysis in API and formulation models based on PXRD, FTIR and Raman scanning imaging combined with univariate and multivariate analyses |
URI | https://dx.doi.org/10.1016/j.talanta.2025.127568 https://www.ncbi.nlm.nih.gov/pubmed/39923672 https://www.proquest.com/docview/3165080636 https://www.proquest.com/docview/3242059606 |
Volume | 287 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5CekgvJU36SNqELeQY2XrsQz4aN8ZuIQSTgG_LvgQKWE5iO8f-ov7IzqxWMYG0gR5XzKBhZ5j5RpoHIWfaScaM5okohUsA37JEB1u2TAODk5kLVb6XYnLDfsz5fIeMul4YLKuMvr_16cFbxyf9eJv9u7rGHl8IrpAf5DwAD_TDjEm08t6vbZkHQOw4eHeQIPW2i6d_i0MGQX4cP5TzHo46x4mrL8env-HPEIfG--RdBJB02Mr4nuz45oDsjbq9bYfk9-hptSBdVhTS6YVf1w_LBb3f6NBo9OipjrNIaN3Q4dUUzo4ifI3LvGhYkLOiGOMchfPVfPb9nI6vp7NAOtML3dCVbRce0XoRdh1RuERItIEDv-7STVM_ghwAZgNPKF3cPsD3-9UHcjO-uB5NkriTIbEFE-skr0qR-VxWHkzQpal1eWZTJwWrIPEpIH2rBkKXRjJjbemEl6XjvDAV5HFVmvriI9ltlo3_TKguhLWygGvXkKT73Jjccm_0QBvLjaiOSK_ThLprR2-oribtVkXVKVSdalV3RMpOX-qZDSkID6-xfuv0q0Bd-NNEN365WakiQwwLQE78gwZwDq4xSoHmU2scTxLj4N9CyPz4_4X7Qt7iCWsWMv6V7K4fNv4EoNDanAZbPyVvhtOfk8s_Nq4MaA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBaK7tBdhr3XPTlgxznxQ5KdY5EtSLauKIIUyE3Qy4ALxGmbpMf9ov3IkbLcYMAewI6SKVgWafGjTfFj7IN2JedGi0RW0iWIb3migy1brnGAKzMXsnzP5PSCf1mK5QEb92dhKK0y7v3dnh5269gzjKs5vGoaOuOLzhXjg1wE4IH78D2Ory_RGAy-7_M8EGPHyrujhMT3x3iGl1RlEB-A6g_lYkC1zqnk6u8d1J8AaHBEk4fsQUSQcNJN8hE78O1jdjTuiduesB_jO25BWNeA8fTKb5ub9QqudzqcNLr1oGMxEmhaODmfYdsB4dfI5gWBIWcD5OQcYPt8Of_0ESaL2TyIzvVKt7CxHeMRNKtAdgS4ihhp4wj6vAu7trnFeSCaDWNC7uK-g-7vN0_ZxeTzYjxNIilDYgsut0leVzLzeVl7tEGXptblmU1dKXmNkU-B8Vs9kroyJTfWVk76snJCFKbGQK5OU188Y4ftuvUvGOhCWlsWuOwao3SfG5Nb4Y0eaWOFkfUxG_SaUFdd7Q3VJ6Vdqqg6RapTneqOWdXrS_1iRAr9w7-Gvu_1q1Bd9NdEt36926giIxCLSE7-RQaBDvEYpSjzvDOOuxlT5d9ClvnL_5_cO3Y0XXw7Vaezs6-v2H26QgkMmXjNDrc3O_8GcdHWvA12_xM3ew32 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+resmetirom+quantative+analysis+in+API+and+formulation+models+based+on+PXRD%2C+FTIR+and+Raman+scanning+imaging+combined+with+univariate+and+multivariate+analyses&rft.jtitle=Talanta+%28Oxford%29&rft.au=Yang%2C+Chen&rft.au=Luo%2C+Ying&rft.au=Sun%2C+Wenxia&rft.au=Liu%2C+Xiangkui&rft.date=2025-05-15&rft.eissn=1873-3573&rft.volume=287&rft.spage=127568&rft_id=info:doi/10.1016%2Fj.talanta.2025.127568&rft_id=info%3Apmid%2F39923672&rft.externalDocID=39923672 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-9140&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-9140&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-9140&client=summon |